Garelius, H K G, Smith, Alexandra Gwen orcid.org/0000-0002-1111-966X, Bagguley, Timothy Charles orcid.org/0000-0002-6150-3467 et al. (20 more authors) (2022) Erythropoietin stimulation agents significantly improves outcome in lower risk MDS. HemaSphere. S168. pp. 69-70. ISSN 2572-9241
Abstract
The EUMDS Registry started in 2008 as a prospective, non-interventional longitudinal study, enrolling newly diagnosed patients with IPSS low or intermediate-1 MDS from 16 European countries and Israel.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Sciences (York) > Health Sciences (York) |
Depositing User: | Pure (York) |
Date Deposited: | 28 Jun 2022 08:50 |
Last Modified: | 09 Nov 2024 01:23 |
Published Version: | https://doi.org/10.1097/01.hs9.0000843564.40783.b4 |
Status: | Published |
Refereed: | Yes |
Identification Number: | 10.1097/01.hs9.0000843564.40783.b4 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:188510 |
Download
Filename: S168_ERYTHROPOIETIN_STIMULATION_AGENTS.69.pdf
Description: S168__ERYTHROPOIETIN_STIMULATION_AGENTS.69
Licence: CC-BY 2.5